SINTILIMAB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where SINTILIMAB was used for Neoplasm malignant.
Most Reported Side Effects for SINTILIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 127 | 19.5% | 2 | 63 |
| Nausea | 77 | 11.8% | 4 | 8 |
| Rash | 72 | 11.0% | 6 | 12 |
| Vomiting | 68 | 10.4% | 3 | 8 |
| Off label use | 64 | 9.8% | 13 | 29 |
| Hypothyroidism | 62 | 9.5% | 3 | 2 |
| Diarrhoea | 61 | 9.4% | 3 | 7 |
| Fatigue | 60 | 9.2% | 4 | 3 |
| Anaemia | 59 | 9.1% | 2 | 7 |
| Pyrexia | 51 | 7.8% | 1 | 15 |
| Therapy partial responder | 51 | 7.8% | 1 | 0 |
| Thrombocytopenia | 51 | 7.8% | 3 | 3 |
| Hypertension | 48 | 7.4% | 2 | 1 |
| Leukopenia | 45 | 6.9% | 1 | 1 |
| Neutropenia | 45 | 6.9% | 2 | 6 |
Other Indications for SINTILIMAB
Gastric cancer (91)
Hepatocellular carcinoma (70)
Lung neoplasm malignant (33)
Colorectal cancer metastatic (30)
Hepatic cancer (24)
Lung adenocarcinoma (19)
Tumour thrombosis (19)
Adenocarcinoma gastric (18)
Non-small cell lung cancer (18)
Lung squamous cell carcinoma stage iii (15)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)